Patents by Inventor Nathan Sallee

Nathan Sallee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOASSAY FOR T-CELL CO-STIMULATORY PROTEINS CONTAINING FC DOMAINS
    Publication number: 20220348657
    Abstract: Provided herein are components (e.g., cells and soluble proteins), systems, and methods for assessing the biological activity of soluble proteins comprising an Fc domain and a CD28-binding domain (e.g., CD80 extracellular domain Fc fusion proteins).
    Type: Application
    Filed: April 17, 2020
    Publication date: November 3, 2022
    Inventors: Luis BORGES, Artur KARASYOV, Zheng MENG, Shawn RUSSELL, Nathan SALLEE, Hongbing ZHANG, Aileen ZHOU
  • SLAMF1 ANTAGONISTS AND USES THEREOF
    Publication number: 20180016555
    Abstract: Methods of identifying and using SLAMF1 antagonists are provided.
    Type: Application
    Filed: October 21, 2015
    Publication date: January 18, 2018
    Applicant: Five Prime Therapeutics, Inc.
    Inventors: Luis Borges, Nathan Sallee, Charles Kaplan, Arthur Brace, W. Michael Kavanaugh, Brian Wong, David Bellovin, Thomas Brennan, Artur Karasyov